Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesInsulin-like factor 3 as a marker of testicular function in obese men
Clinical Endocrinology, 10/16/09
Foresta C et al. – This study showed for the first time that INSL3 levels decrease with obesity, probably as a result of a primary dysfunction of the Leydig cells. INSL3 is a reliable marker of Leydig cell general impairment, whereas T mainly reflects the steroidogenic activity of these cells.
Today in Obesity...keeping you current
Receive free subspecialty "5-minute updates" via email
An integrative view of obesity
American Journal of Clinical Nutrition, 11/19/09
Marine Omega-3 Fatty Acid Intake: Associations with Cardiometabolic Risk and Response to Weight Loss Intervention in The Look AHEAD Study
Diabetes Care, 11/05/09
Comparison of Combined Bupropion and Naltrexone Therapy for Obesity with Monotherapy and Placebo
Journal of Clinical Endocrinology and Metabolism, 10/29/09
Sponsor
Article Search
Sponsor